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A case of murine typhus in Yucatan was diagnosed in 
a child with nonspecific signs and symptoms. The finding of 
Rickettsia typhi increases the number of Rickettsia species 
identified in Yucatan and shows that studies are needed to 
determine the prevalence and incidence of rickettsioses in 
Mexico.
M
urine typhus is a worldwide febrile illness caused 
by Rickettsia typhi, which is frequently associated 
with exposure to reservoir animals and their ectoparasites 
(1,2). Patients with murine typhus often have nonspecific 
signs and symptoms that mimic those of common febrile 
illnesses. Although the disease is generally self-limited, it 
sometimes has complications that require hospitalization 
and can even cause death if the appropriate timely treat-
ment is not administered (3,4). Antimicrobial drug treat-
ment dramatically reduces the symptomatic period as well 
as the economic effects by lowering expenses and minimiz-
ing loss of productivity. 
Information about murine typhus in Mexico is scarce. 
Recently, a study of healthy adult blood donors in Mexi-
co City showed a prevalence of antibodies against typhus 
group rickettsiae (using R. typhi antigen) of 14% (5).
The Study
In June 2007, a 3 year-old girl was brought to the emer-
gency room of the public hospital with a fever of 3 days’ 
duration. Her mother reported that the child had close con-
tact with domestic animals (cat and dog), that mice were 
present in the house, and that the child had flea bites on her 
legs and arms 2 days before the onset of fever. The illness 
began with a high fever (39.8°C), abdominal pain, head-
ache, fatigue, and myalgia. The patient’s condition was di-
agnosed as viral pharyngitis and otitis media, and she was 
treated as an outpatient with nimesulide, amoxicillin, and 
trimethoprim; she did not respond to this treatment. Ten 
days after the first hospital visit, the girl was hospitalized 
with the diagnosis of Salmonella typhi infection because 
of serologic reactivity with O and H antigens (titers of 160 
and 80, respectively). At time of admission, she had a high 
fever (39.8°C), arthralgia in the hands and ankles, and a 
petechial maculopapular rash on the thorax and extremi-
ties.  She  was  treated  with  sulfonamide,  cephalosporin, 
and acetaminophen without remission of the symptoms. 
Clinical laboratory evaluation showed the following: neu-
trophilic leukocytosis, hemoglobin 10.1 g/dL, hematocrit 
30.3%, thrombocytopenia (40 × 106 platelets/L [reference 
range 140–440 × 106 platelets/L]), elevated serum alkaline 
phosphatase (290 U/L [reference range 35–104 U/L]), el-
evated lactic dehydrogenase concentration (560 U/L [refer-
ence range 100–190 U/L]), and elevated antistreptolysin O 
and rheumatoid factor titers.
The diagnosis of murine typhus was established by 
PCR  for  Rickettsia  17  kDa  and  citrate  synthase  (gltA) 
genes  as  described  previously  (6,7).  Positive  controls 
were DNA of Rickettsia felis, R. rickettsii, R. akari, and 
R. typhi, and 1 reaction without DNA was used as a neg-
ative control. The DNA of the controls and the patient 
were handled separately to avoid contamination. R. typhi 
was identified as the causal agent by restriction fragment 
length polymorphism analysis (RFLP) of the amplified 
fragment of gltA (382 bp) and 17-kDa gene (434 bp) by 
using  AluI as described previously (7,8) (Figure) and by 
comparing the DNA sequences of the gltA and 17-kDa 
gene PCR amplicons using BLAST software of the Na-
tional Center for Biotechnology Information (Bethesda, 
MD,  USA)  (9).  The  sequences  showed  100%  identity 
with the corresponding R. typhi genes (Table).
An indirect immunofluorescence assay (IFA) was per-
formed for serologic diagnosis; R. akari, R. rickettsii, and 
R. typhi antigens were fixed on slides. (A positive human 
serum sample control and IFA slides were provided by the 
Rickettsial and Ehrlichial Diseases Research Laboratory, 
University of Texas Medical Branch at Galveston.) As a 
negative control, we used a serum sample (from a healthy 
donor) that was negative for Leptospira spp. (microscopic 
agglutination test and PCR); rickettsiae (IFA and PCR); 
HIV (microparticle enzyme immunoassay and PCR); hepa-
titis A, B, and C viruses (microparticle enzyme immuno-
assay); Toxoplasma gondii (ELISA); and Mycobacterium 
tuberculosis (ELISA, PCR).
We examined the serum specimens for immunoglobu-
lin (Ig) G and IgM, assessing reactivity of γ-chain–specific 
and μ-heavy-chain–specific secondary conjugates, respec-
tively, with rickettsial antigens. A serum sample collected 
20 days after onset of the illness was serially diluted to 
1:4,096 to determine the end-point titer. IFA showed an-
tibody reactivity with R. typhi, R. rickettsii, and R. akari 
(Table). The child was treated with intravenous chloram-
phenicol, 75 mg/kg per day, for 7 days; symptoms were 
reduced in 48 hours.
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Conclusions
In Yucatan state we have identified several cases of 
rickettsiosis caused by R. felis and R. rickettsii, some with 
fatal outcome, but not with R. typhi infection (10,11). Since 
we reported an emerging human rickettsiosis in Mexico 12 
years ago, a surveillance system and educational efforts 
have been put in place to promote more timely diagnosis 
and treatment of rickettsioses. As a result of such efforts, 
we have also been able to detect new rickettsioses in the 
Yucatan Peninsula.
R.  typhi  is  a  bacterium  that  is  broadly  distributed 
around the world, and is the cause of many human infec-
tions every year (12,13). As with other febrile illnesses, 
children are a vulnerable population frequently exposed to 
this pathogen (4,14).
In Mexico, human proximity to domestic animals is 
common, and the habitats of both have a close relationship. 
In rural and suburban areas, for example, opossums, rats, 
and mice often inhabit backyards and houses. The potential 
transmission cycle of many vector-borne diseases, includ-
ing rickettsioses, is evident through human exposure to ec-
toparasite vectors.
IFA showed serum IgM and IgG antibody reactivity 
with R. typhi and IgG antibody reactivity with R. rickettsii 
and R. akari. In our experience, IFA supports the diagnosis 
but sometimes is not conclusive because of cross-reactivity 
among species of the spotted fever group and the typhus 
group (15). However, we cannot exclude the possibility 
of other prior infections because of the living conditions 
and the presence of various rickettsial species in our envi-
ronment in Yucatan. For that reason, we conduct PCR to 
diagnose human rickettsiosis. Our criteria for a confirmed 
diagnosis of any rickettsial infection are the same as those 
published by the US Centers for Disease Control and Pre-
vention (Atlanta, GA, USA) for Rocky Mountain spotted 
fever: a clinically compatible case with a 4-fold change in 
IgG-specific antibody titer reactive with a rickettsial anti-
gen by IFA between paired serum specimens or detection 
of rickettsial DNA in a blood, biopsy, or autopsy specimen 
through amplification of a specific target by PCR.
The identity of R. typhi was established not only by the 
RFLP pattern of the gltA and 17-kDa gene amplicons, but 
mainly by the sequence comparison with other rickettsial 
species. Identity was 100% for R. typhi (Table). Identifica-
tion of the Rickettsia species is essential for determining 
the epidemiology and ecology of the transmission cycle 
and how the agent is maintained in nature. In addition, spe-
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Figure. Restriction fragment length polymorphism patterns of gltA 
(A) and 17-kDa gene (B) PCR products digested with AluI. Lane 
1, undigested gltA and 17-kDa gene PCR amplicons (from blood 
sample of infected child); lane 2, human case; lane 3, Rickettsia 
typhi–positive control; lane 4, R. felis–positive control; lane 5, R. 
akari–positive control; lane 6, R. rickettsii–positive control.
Table. Methods used to diagnose human Rickettsia typhi infection, Yucatan, Mexico, 2007* 
PCR, % identity  IFA, titer† 
Sample  Citrate synthase (gltA) (382 bp)‡  17-kDa gene (434 bp)§    IgM  IgG 
Rickettsia typhi Wilmington strain 100 (AE017197.1)  100 (M28481.1), 99 (AE017197.1)    256  128 
R. felis URRWXCal2 NR  89 (CP000053.1)    ND   
R. rickettsii Sheila Smith  92 (CP000848.1)  89 (CP000848.1)    Neg  128 
R. akari Hartford strain 91 (CP000847.1)  96 (CP000847.1)    Neg  64 
*IFA, indirect immunofluorescence assay; Ig, immunoglobulin; NR, not represented in the first 100 sequences with a significant alignment using BLAST 
(9);  ND, not determined; Neg, negative. 
†Titers refer to the reciprocal of the dilution. 
‡Primers: RpCS.1258 5ƍ-ATTGCAAAAA GTACCGTAAACA-3ƍ and RpCS.877 5ƍ-GCCCCGCCGTGGGCAGGCCCCC-3ƍ. 
§Primers: 17-kDa 5ƍ-GCTCTTGCAACTTCTATGTT-3ƍ and 5ƍ-CATTGTTCGTCAGGTTGGCG-3ƍ. cies identification is useful for selecting the best preventive 
program appropriate for each region.
This finding of an autochthonous human case of mu-
rine typhus in Yucatan Mexico and the finding of R. typhi 
in  Yucatan  state  increases  the  diversity  of  rickettsioses 
identified in this ecosystem. Because rickettsioses are treat-
able diseases, an educational program is critical to instruct 
the population about these infections and their transmission 
cycles, as well as to inform the medical community about 
the rickettsial diseases that must be included in the differ-
ential diagnosis of any acute febrile illnesses in the region.
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